Resident

Keyword Search

  • Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

    Read More

  • PBM 101: Why the Model Matters

    Read More

  • Associate Resource Group Spotlight: Green Team

    Read More

  • PBM 101: The Three PBM Business Models

    Read More

  • An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

    Read More

  • Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

    Read More

  • Achieving Outstanding Results with Tailored Network Strategies

    Read More

  • Breaking Through Barriers with Value-Based Plan Design

    Read More

  • Finding a Solution to Lower Prescription Drug Costs

    Read More

  • Empowered by Strategic Opportunities and Service Excellence

    Read More

  • QALYiQ Program Delivers Significant Savings for Both Members and Health Plans

    Read More

  • RISE: Reporting and Intervention for Stars Excellence

    Read More

  • Medication Therapy Management: Improving Health Outcomes and Reducing Cost

    Read More

  • Personalized Member Transitions: Creating a Smoother Benefit Transition

    Read More

  • Pharmacy and Practitioner Exclusions and How to Resolve Them

    Read More

  • Rx Money Saving Tips

    Read More

  • Fraud, Waste, and Abuse

    Read More

  • Participating Pharmacy Network Listing – National and Regional Chains/Groups

    Read More
Portal Login
Beware of Groups Posing as Navitus
Learn More
This is default text for notification bar
Learn more